We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-39.24%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$13.6M
AUM Growth
-$133M
Cap. Flow
-$123M
Cap. Flow %
-901.55%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$65.9M
2
TECX
Tectonic Therapeutic
TECX
+$47.5M
3
DYN icon
Dyne Therapeutics
DYN
+$9.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$481M
$8.73M 64.02%
4,523,924
– –
ALLO icon
2
Allogene Therapeutics
ALLO
$604M
$2.63M 19.25%
1,798,163
– –
KRON
3
DELISTED
Kronos Bio
KRON
$2.28M 16.73%
2,765,314
– –
CNTA
4
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-3,931,818
Closed -$65.9M
DYN icon
5
Dyne Therapeutics
DYN
$4.24B
– –
-407,499
Closed -$9.6M
TECX
6
Tectonic Therapeutic
TECX
$578M
– –
-1,028,674
Closed -$47.5M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Vida Ventures Advisors held 6 positions worth $13.6M, down 91% from $146M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors withdrew a net $123M in Q1 2025, closing 3 positions. Its most notable exit was Centessa Pharmaceuticals, an estimated $65.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors fully exited Centessa Pharmaceuticals in Q1 2025, selling an estimated $65.9M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $13.6M portfolio in Q1 2025.
  • Vida Ventures Advisors opened 0 new positions and closed 3 in Q1 2025.
  • Vida Ventures Advisors's portfolio value fell 91% quarter-over-quarter to $13.6M.

Based on Vida Ventures Advisors's 13F filing for Q1 2025, filed 3 Apr 2025.